MRK

Merck & Co., Inc.

US StockNYSEPharmaceutical Preparations

Research the business. Follow the filings.

Financial information from SEC disclosures, with reporting periods kept in context.

Revenue

65B USDAnnual · FY 2025

Net income

18.3B USDAnnual · FY 2025

Total assets

136.9B USDAnnual · FY 2025

Equity

52.6B USDAnnual · FY 2025

Operating cash flow

16.5B USDAnnual · FY 2025

Revenue growth

1.3%Annual · FY 2025

MRK · Chart

Chart provided by TradingView. Loading the chart connects your browser to TradingView and sends necessary technical information such as your IP address, page URL, and displayed symbol.

Reported financial information

Revenue

USD

65B USD

Period data
PeriodValue
FY 202148.7B USD
FY 202259.3B USD
FY 202360.1B USD
FY 202464.2B USD
FY 202565B USD

Operating income

USD

No applicable data available

No applicable data available

Net income

USD

18.3B USD

Period data
PeriodValue
FY 202113B USD
FY 202214.5B USD
FY 2023365M USD
FY 202417.1B USD
FY 202518.3B USD

Total assets

USD

136.9B USD

Period data
PeriodValue
FY 2021105.7B USD
FY 2022109.2B USD
FY 2023106.7B USD
FY 2024117.1B USD
FY 2025136.9B USD

Equity

USD

52.6B USD

Period data
PeriodValue
FY 202138.3B USD
FY 202246.1B USD
FY 202337.6B USD
FY 202446.3B USD
FY 202552.6B USD

Operating cash flow

USD

16.5B USD

Period data
PeriodValue
FY 202010.3B USD
FY 202219.1B USD
FY 202313B USD
FY 202421.5B USD
FY 202516.5B USD

Revenue growth

%

1.3%

Period data
PeriodValue
FY 202117.3%
FY 202221.7%
FY 20231.4%
FY 20246.7%
FY 20251.3%

Operating income growth

%

No applicable data available

No applicable data available

Net income growth

%

6.6%

Period data
PeriodValue
FY 202184.6%
FY 202211.3%
FY 2023-97.5%
FY 20244,589.6%
FY 20256.6%

Operating margin

%

No applicable data available

No applicable data available

Net margin

%

28.1%

Period data
PeriodValue
FY 202126.8%
FY 202224.5%
FY 20230.6%
FY 202426.7%
FY 202528.1%

Return on assets

%

14.4%

Period data
PeriodValue
FY 202113.2%
FY 202213.5%
FY 20230.3%
FY 202415.3%
FY 202514.4%

Debt/Equity

x

No applicable data available

Period data
PeriodValue
FY 2021N/A
FY 2022N/A
FY 2023N/A
FY 2024N/A
FY 2025N/A